Celogos has developed a solid patent-protected technology platform called Rational Cell Design (RCD). Proof of concept has already been demonstrated in an animal model. Currently RCD is used for discovery, optimisation, production and delivery of new cell-based therapeutics products.
Rational Cell Design can:
- offer well-characterised, quality-controlled and reproducible cellular products
- ensure high production capacities associated with short production time
- include a freezing stage allowing product conservation before patient administration.
Rational Cell Design's process includes clinical and production stages.
The therapeutics chain is presented below:
